Seneca Biopharma (STU:7NS2) Days Payable : 0.00 (As of Dec. 2020)

View and export this data going back to 2013. Start your Free Trial

What is Seneca Biopharma Days Payable?

Seneca Biopharma's average Accounts Payable for the three months ended in Dec. 2020 was €0.51 Mil. Seneca Biopharma's Cost of Goods Sold for the three months ended in Dec. 2020 was €0.00 Mil.

The historical rank and industry rank for Seneca Biopharma's Days Payable or its related term are showing as below:

STU:7NS2's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 147.375
* Ranked among companies with meaningful Days Payable only.

Seneca Biopharma's Days Payable stayed the same from Dec. 2019 (0.00) to Dec. 2020 (0.00). stayed the same

Seneca Biopharma Days Payable Historical Data

The historical data trend for Seneca Biopharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seneca Biopharma Days Payable Chart

Seneca Biopharma Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Days Payable

Get a 7-Day Free Trial

Seneca Biopharma Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Seneca Biopharma's Days Payable

For the Biotechnology subindustry, Seneca Biopharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Seneca Biopharma's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Seneca Biopharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Seneca Biopharma's Days Payable falls into.

Seneca Biopharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Seneca Biopharma's Days Payable for the fiscal year that ended in Dec. 2020 is calculated as

	Days Payable (A: Dec. 2020 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2019 )	+	Accounts Payable (A: Dec. 2020 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2020 )	*	Days in Period
=	( (0.742	+	0.533)	/	2 )	/	0	*	365
=	0.6375					/	0	*	365
=	N/A

Seneca Biopharma's Days Payable for the quarter that ended in Dec. 2020 is calculated as:

	Days Payable (Q: Dec. 2020 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2020 )	+	Accounts Payable (Q: Dec. 2020 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2020 )	*	Days in Period
=	( (0.491	+	0.533)	/	2 )	/	0	*	365 / 4
=	0.512					/	0	*	365 / 4
=	N/A

Seneca Biopharma Days Payable Related Terms

Thank you for viewing the detailed overview of Seneca Biopharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Seneca Biopharma (STU:7NS2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seneca Biopharma Inc (STU:7NS2) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

20271 Goldenrod Lane, Suite 2024, Germantown, MD, USA, 20876

Website

https://www.senecabio.com

Seneca Biopharma Inc is a clinical-stage biopharmaceutical company developing novel treatments for diseases of high unmet medical need. It is focused on the research and development of nervous system therapies based on proprietary human neural stem cells and small molecule compounds.

Seneca Biopharma (STU:7NS2) Headlines

No Headlines